Jaundice natural history, complications, and prognosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
m (Bot: Removing from Primary care)
 
(12 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Jaundice}}
{{Jaundice}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{FA}}


==Overview==
==Overview==
The type and the severity of complications depends on the underlying cause leading to jaundice. Certain individuals may not suffer any long-term complications and recovers fully, while for others the appearance of jaundice may be the first indication of a life-threatening situation.  
Natural history of jaundice varies greatly and symptoms can manifest at any age of life depending on the underlying cause. The type and the severity of complications depends on the underlying cause leading to jaundice. Certain individuals may not suffer any long-term complications and recovers fully, while for others the appearance of jaundice may be the first indication of a life-threatening situation.  


==Natural History==
==Natural History, Complications, and Prognosis==
* The symptoms of (disease name) usually develop in the first/ second/ third decade of life, and start with symptoms such as ___.
* The symptoms of (disease name) typically develop ___ years after exposure to ___.
* If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].


=== Natural History ===
*Jaundice may develop as early as [[neonatal]] period to any decade of life depending on the underlying cause, and presents as yellowish discoloration of skin and [[sclera]].<ref name="pmid204973612">{{cite journal| author=Gundur NM, Kumar P, Sundaram V, Thapa BR, Narang A| title=Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn. | journal=Pediatr Int | year= 2010 | volume= 52 | issue= 5 | pages= 769-72 | pmid=20497361 | doi=10.1111/j.1442-200X.2010.03170.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20497361  }}</ref>
*Typically, [[jaundice]] is not evident clinically until serum [[bilirubin]] level reaches 2.5 mg/dL. It is first seen in the [[conjunctiva]] or oral [[Mucous membrane|mucous membranes]] such as the [[hard palate]] or under the [[tongue]]. As the serum concentration of [[bilirubin]] rises, [[jaundice]] proceeds cephalo-caudally.
*[[Jaundice]] appearing over a few days to couple of  week implies an [[Acute (medicine)|acute]] course ([[hepatitis]], whether [[drug]] or [[toxin]] induced, [[viral]] or [[bacterial]] i.e., [[leptospirosis]]).<ref name="pmid41915022">{{cite journal| author=Krugman S, Giles JP| title=Viral hepatitis. New light on an old disease. | journal=JAMA | year= 1970 | volume= 212 | issue= 6 | pages= 1019-29 | pmid=4191502 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=4191502  }}</ref>
*[[Jaundice]] appearing over the course of few weeks points towards a [[subacute]] [[hepatitis]] or extrahepatic obstruction ([[malignancy]], [[gallstone]], [[chronic pancreatitis]], or [[stricture]] in the [[common bile duct]]).
*Jaundice of fluctuating intensity implicates [[gallstones]], [[Ampulla of Vater|ampullary carcinoma]], or possible [[drug]] [[hepatitis]].<ref name="pmid159609302">{{cite journal| author=Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A et al.| title=Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage. | journal=Clin Transl Oncol | year= 2005 | volume= 7 | issue= 5 | pages= 189-97 | pmid=15960930 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15960930  }}</ref><ref name="pmid214608762">{{cite journal| author=Patel T| title=Cholangiocarcinoma--controversies and challenges. | journal=Nat Rev Gastroenterol Hepatol | year= 2011 | volume= 8 | issue= 4 | pages= 189-200 | pmid=21460876 | doi=10.1038/nrgastro.2011.20 | pmc=3888819 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21460876  }}</ref>
*If left untreated, approximately 2 out of 100,000 patients in USA with [[jaundice]] may progress to develop [[Acute (medicine)|acute]] [[Hepatic failure|liver failure]] leading to heptocyte dysfunction, which imanifests as sudden onset of [[encephalopathy]] and [[coagulopathy]] in a healthy person with no known underlying [[liver]] [[disease]].<ref name="Ostapowicz2002">{{cite journal|last1=Ostapowicz|first1=George|title=Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States|journal=Annals of Internal Medicine|volume=137|issue=12|year=2002|pages=947|issn=0003-4819|doi=10.7326/0003-4819-137-12-200212170-00007}}</ref>


==Complications==
==Complications==
Common complications of jaundice include:<ref name="pmid28272079">{{cite journal| author=Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV et al.| title=Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis. | journal=J Clin Gastroenterol | year= 2017 | volume= 51 | issue= 6 | pages= 548-556 | pmid=28272079 | doi=10.1097/MCG.0000000000000805 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28272079  }}</ref>
Common complications of jaundice include:<ref name="pmid28272079">{{cite journal| author=Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV et al.| title=Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis. | journal=J Clin Gastroenterol | year= 2017 | volume= 51 | issue= 6 | pages= 548-556 | pmid=28272079 | doi=10.1097/MCG.0000000000000805 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28272079  }}</ref>
* Electrolyte abnormalities
* [[Electrolyte abnormalities]]
* [https://www.medicinenet.com/anemia/symptoms.htm Anemia]
* [[Anemia]]
* [[Bleeding]]
* [[Infection]]/[[sepsis]]
* [[Infection]]/[https://www.medicinenet.com/sepsis/article.htm sepsis]
* [[Chronic hepatitis]]
* [[Chronic hepatitis]]
* [[Cancer]]
* [[Cancer]]
* [[Hepatic failure|Liver failure]]
* [[Hepatic failure|Liver failure]]
* [https://www.medicinenet.com/kidney_failure/article.htm Kidney failure]
** [[Bleeding]] and [[coagulopathy]]
* [https://www.medicinenet.com/encephalopathy/article.htm Hepatic encephalopathy] (brain dysfunction)
** [[Hepatic encephalopathy]] (brain dysfunction)
* Death
** Death
* [[Kidney failure]]


==Prognosis==
==Prognosis==
* Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
* The prognosis for individuals with [[jaundice]] varies with the underlying cause of the condition.
* Depending on the extent of the [tumor/disease progression/etc.] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
* There are certain conditions that has the most favorable prognosis leading to full recovery.
* The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
* However, more serious causes of jaundice like [[Acute (medicine)|acute]] [[suppurative]] [[cholangitis]] or [[Fulminant Hepatic Failure|fulminant hepatic failure]] can sometimes be fatal despite medical or surgical intervention. The mortality can be as high as 80% .<ref name="pmid8305063">{{cite journal| author=Lee WM| title=Acute liver failure. | journal=N Engl J Med | year= 1993 | volume= 329 | issue= 25 | pages= 1862-72 | pmid=8305063 | doi=10.1056/NEJM199312163292508 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8305063  }}</ref> 
* [Subtype of disease/malignancy] is associated with the most favorable prognosis.
* The development and severity of complications as well as patient's underlying health and comorbidities have a huge impact on the prognosis of patients.  
* The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
* The prognosis for individuals with jaundice varies with the underlying cause of the condition. There are certain conditions that has the most favorable prognosis leading to full recovery. However, more serious causes of jaundice like       can sometimes be fatal despite medical or surgical intervention. The development and severity of complications will also determine an individual's prognosis, as will a patient's underlying health and comorbidities (presence of other diseases).


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}
{{WS}}


[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Primary care]]
[[Category:Disease]]
[[Category:Disease]]
[[Category:Gastroenterology]]
[[Category:Gastroenterology]]
[[Category:Hepatology]]
[[Category:Hepatology]]
{{WH}}
{{WS}}

Latest revision as of 22:27, 29 July 2020

Jaundice Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Jaundice from other Conditions

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Chest X Ray

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Jaundice natural history, complications, and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Jaundice natural history, complications, and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Jaundice natural history, complications, and prognosis

CDC on Jaundice natural history, complications, and prognosis

Jaundice natural history, complications, and prognosis in the news

Blogs on Jaundice natural history, complications, and prognosis

Directions to Hospitals Treating Jaundice

Risk calculators and risk factors for Jaundice natural history, complications, and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fatima Shaukat, MD [2]

Overview

Natural history of jaundice varies greatly and symptoms can manifest at any age of life depending on the underlying cause. The type and the severity of complications depends on the underlying cause leading to jaundice. Certain individuals may not suffer any long-term complications and recovers fully, while for others the appearance of jaundice may be the first indication of a life-threatening situation.

Natural History, Complications, and Prognosis

Natural History

Complications

Common complications of jaundice include:[6]

Prognosis

  • The prognosis for individuals with jaundice varies with the underlying cause of the condition.
  • There are certain conditions that has the most favorable prognosis leading to full recovery.
  • However, more serious causes of jaundice like acute suppurative cholangitis or fulminant hepatic failure can sometimes be fatal despite medical or surgical intervention. The mortality can be as high as 80% .[7]
  • The development and severity of complications as well as patient's underlying health and comorbidities have a huge impact on the prognosis of patients.

References

  1. ↑ Gundur NM, Kumar P, Sundaram V, Thapa BR, Narang A (2010). "Natural history and predictive risk factors of prolonged unconjugated jaundice in the newborn". Pediatr Int. 52 (5): 769–72. doi:10.1111/j.1442-200X.2010.03170.x. PMID 20497361.
  2. ↑ Krugman S, Giles JP (1970). "Viral hepatitis. New light on an old disease". JAMA. 212 (6): 1019–29. PMID 4191502.
  3. ↑ Porta M, Fabregat X, Malats N, Guarner L, Carrato A, de Miguel A; et al. (2005). "Exocrine pancreatic cancer: symptoms at presentation and their relation to tumour site and stage". Clin Transl Oncol. 7 (5): 189–97. PMID 15960930.
  4. ↑ Patel T (2011). "Cholangiocarcinoma--controversies and challenges". Nat Rev Gastroenterol Hepatol. 8 (4): 189–200. doi:10.1038/nrgastro.2011.20. PMC 3888819. PMID 21460876.
  5. ↑ Ostapowicz, George (2002). "Results of a Prospective Study of Acute Liver Failure at 17 Tertiary Care Centers in the United States". Annals of Internal Medicine. 137 (12): 947. doi:10.7326/0003-4819-137-12-200212170-00007. ISSN 0003-4819.
  6. ↑ Sonthalia N, Rathi PM, Jain SS, Surude RG, Mohite AR, Pawar SV; et al. (2017). "Natural History and Treatment Outcomes of Severe Autoimmune Hepatitis". J Clin Gastroenterol. 51 (6): 548–556. doi:10.1097/MCG.0000000000000805. PMID 28272079.
  7. ↑ Lee WM (1993). "Acute liver failure". N Engl J Med. 329 (25): 1862–72. doi:10.1056/NEJM199312163292508. PMID 8305063.

Template:WH Template:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Jaundice_natural_history,_complications,_and_prognosis&oldid=1640008"